IMVT
Immunovant, Inc. · Healthcare
Director Atul Pande sold $57K of Immunovant, Inc.
Sold$57,015
$38.01Price
1,500Shares
−1%Stake
What IMVT did after the filing
- The stock from Mon, Jun 29 open, $38.29
- +6.9%
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Aug 11 close.
Traded Fri, Jun 26. Filed Fri, Jun 26, 7:43 PM ET, after the close. Returns use the Jun 29 open and the Aug 11 close. Not investment advice.